Description du projet
Un moyen naturel de garder les poulets en bonne santé
Salmonella et Escherichia coli sont les agents pathogènes infectieux les plus courants chez les volailles. Les antibiotiques sont largement utilisés dans les exploitations agricoles pour traiter les infections, mais leur emploi excessif a entraîné une augmentation de la résistance aux antimicrobiens chez les animaux et les humains. Pour atténuer cet effet, le projet PHAGOVET, financé par l’UE, propose des produits biocides et des additifs alimentaires technologiques rentables basés sur les bactériophages pour cibler et éliminer les bactéries. Il s’agira de la première solution basée sur les phages pour contrôler naturellement ces deux bactéries dans le secteur de la production de volaille tout en évitant les effets secondaires et les résidus associés à l’utilisation d’antibiotiques. Cette alternative naturelle aux antibiotiques profitera à la production de volailles et d’œufs de l’UE, qui compte parmi les plus importantes au monde.
Objectif
The Phagovet project is devised to satisfy market demand for a more secure and reliable solution to control Salmonella and E. coli infections in poultry farms. With more than 40,000 poultry farms, the European Union (EU-28) is the forth world´s top producers in poultry meat (13.1 million tons, 2014) and the second largest egg producer (>11 million tons, 2014). The European poultry industry employs 302,000 staff across Europe and has an annual turnover of €30 B, being then of significant economic importance. To date, avian colibacillosis and salmonellosis are considered the main bacterial infections in the poultry sector having an important economic impact worldwide. Furthermore, EFSA estimated overall economic burden of human salmonellosis at €3B/year. Finally, the overuse of antibiotic in farming has caused a rise in antimicrobial resistance 700,000 people die annually from drug resistant infections and it is estimated that this number will rise to 10 million by 2050. In response to the unmet need, Phagovet proposes a cost-effective alternative to antibiotics against Salmonella and E. coli. Phagovet consists of a biocide and two technological food additive products based on selected bacteriophages able to kill the target bacteria. Phagovet will be the first phage-based solution to naturally and effectively control both bacteria in poultry production while avoiding side effects and residues associated to antibiotic use. It will reduce Sallmonella infections by 20% and reduce the use of antibiotics on E. coli by 50%. Thus, Phagovet provides a promising effective control measure for a concerning problem for poultry farmers and for human health. The successful market launch of Phagovet will enable members of the Consortium to consolidate their position in the Animal Health, Food Safety and Environmental Control markets and commercialize the product worldwide, reaching €17.76M profit at the end of 2026.
Champ scientifique
- medical and health scienceshealth sciencespublic health
- natural sciencesbiological sciencesmicrobiologybacteriology
- natural sciencesbiological sciencesmicrobiologyvirology
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibiotics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Mots‑clés
Programme(s)
Régime de financement
IA - Innovation actionCoordinateur
3460-021 Tondela
Portugal
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.